Literature DB >> 18380349

Alternative splicing in disease.

James P Orengo1, Thomas A Cooper.   

Abstract

Alternative splicing is a major source of diversity in the human proteome. The regulation of alternative splicingmodulates the composition of this diversity to fulfill the physiological requirements of a cell. When control of alternative splicing is disrupted, the result can be a failure to meet cellular and tissue requirements resulting in dysfunction and disease. There are several well-characterized examples in which disruption of alternative splicing is a cause of disease. Investigations into how the mis-regulation of alternative splicing causes disease complements investigations of normal regulatory processes and enhances our understanding of regulatory mechanisms in general Ultimately, an understanding of how alternative splicing is altered in disease will facilitate strategies directed at reversing or circumventing mis-regulated splicing events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18380349     DOI: 10.1007/978-0-387-77374-2_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  34 in total

Review 1.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

Review 2.  Alternative splicing and the evolution of phenotypic novelty.

Authors:  Stephen J Bush; Lu Chen; Jaime M Tovar-Corona; Araxi O Urrutia
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-02-05       Impact factor: 6.237

Review 3.  Alternative splicing: a pivotal step between eukaryotic transcription and translation.

Authors:  Alberto R Kornblihtt; Ignacio E Schor; Mariano Alló; Gwendal Dujardin; Ezequiel Petrillo; Manuel J Muñoz
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02-06       Impact factor: 94.444

Review 4.  Alternative splicing isoforms in health and disease.

Authors:  Hyoung Kyu Kim; Michael Huy Cuong Pham; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Pflugers Arch       Date:  2018-03-13       Impact factor: 3.657

5.  The impact of RABL2B gene (rs144944885) on human male infertility in patients with oligoasthenoteratozoospermia and immotile short tail sperm defects.

Authors:  Seyedeh Hanieh Hosseini; Mohammad Ali Sadighi Gilani; Anahita Mohseni Meybodi; Marjan Sabbaghian
Journal:  J Assist Reprod Genet       Date:  2017-01-30       Impact factor: 3.412

Review 6.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

7.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.

Authors:  Karrie E Grear; I-Fang Ling; James F Simpson; Jennifer L Furman; Christopher R Simmons; Shawn L Peterson; Frederick A Schmitt; William R Markesbery; Qiang Liu; Julia E Crook; Steven G Younkin; Guojun Bu; Steven Estus
Journal:  Mol Neurodegener       Date:  2009-11-04       Impact factor: 14.195

8.  Proteomic characteristics of the liver and skeletal muscle in the Chinese tree shrew (Tupaia belangeri chinensis).

Authors:  Rongxia Li; Wei Xu; Zhen Wang; Bin Liang; Jia-Rui Wu; Rong Zeng
Journal:  Protein Cell       Date:  2012-08-12       Impact factor: 14.870

Review 9.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Investigating the genetic association between ERAP1 and ankylosing spondylitis.

Authors:  David Harvey; Jennifer J Pointon; David M Evans; Tugce Karaderi; Claire Farrar; Louise H Appleton; Roger D Sturrock; Millicent A Stone; Udo Oppermann; Matthew A Brown; B Paul Wordsworth
Journal:  Hum Mol Genet       Date:  2009-08-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.